BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26119800)

  • 1. Infantile Bullous Pemphigoid Treated Using Intravenous Immunoglobulin: Case Report and Review of the Literature.
    Tekin B; Yücelten AD
    Pediatr Dermatol; 2015; 32(5):723-6. PubMed ID: 26119800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Half-half" blisters in bullous pemphigoid successfully treated with adjuvant high-dose intravenous immunoglobulin.
    Pacheco D; Lopes L; Soares-Almeida L; Marques MS; Filipe P
    Acta Dermatovenerol Alp Pannonica Adriat; 2012 Sep; 21(3):59-61. PubMed ID: 23267874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infantile bullous pemphigoid successfully treated with intravenous immunoglobulin therapy.
    Watanabe T; Hara S; Muto J; Watanabe D; Akiyama M
    Clin Exp Dermatol; 2017 Jul; 42(5):576-578. PubMed ID: 28543802
    [No Abstract]   [Full Text] [Related]  

  • 4. Infantile bullous pemphigoid treated with intravenous immunoglobulin therapy.
    Sugawara N; Nagai Y; Matsushima Y; Aoyama K; Ishikawa O
    J Am Acad Dermatol; 2007 Dec; 57(6):1084-9. PubMed ID: 17889964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infantile bullous pemphigoid successfully treated with combined pulse corticosteroids and high-dose IVIG.
    Wawrzycki B; Krasowska D; Pietrzak A; Szumilo J; Blazowski L; Pietraszek-Mamcarz J; Lotti T
    Dermatol Ther; 2018 Sep; 31(5):e12635. PubMed ID: 30216603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive clinical outcome in a patient with recalcitrant bullous pemphigoid treated with rituximab and intravenous immunoglobulin.
    Nguyen T; Ahmed AR
    Clin Exp Dermatol; 2017 Jul; 42(5):516-519. PubMed ID: 28508388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postvaccinal, corticosteroid-resistant bullous pemphigoid in infancy: treatment with intravenous immunoglobulin.
    Ister M; Pouessel G; Ythier H; Catteau B; Carpentier O
    Pediatr Dermatol; 2014; 31(4):e94-5. PubMed ID: 24916151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood bullous pemphigoid treated by i.v. immunoglobulin.
    Xiao T; Li B; Wang YK; He CD; Chen HD
    J Dermatol; 2007 Sep; 34(9):650-3. PubMed ID: 17727369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bullous pemphigoid treated with intravenous immunoglobulin.
    Tuchinda P; Ritchie S; Gaspari AA
    Cutis; 2014 May; 93(5):264-8. PubMed ID: 24897141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose intravenous immunoglobulin in the treatment of adult patients with bullous pemphigoid.
    Gaitanis G; Alexis I; Pelidou SH; Gazi IF; Kyritsis AP; Elisaf MS; Bassukas ID
    Eur J Dermatol; 2012; 22(3):363-9. PubMed ID: 22548754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulins in infantile dyshidrosiform bullous pemphigoid refractory to steroids and dapsone.
    Viglizzo G; Herzum A; Cozzani E; Occella C; Parodi A
    Dermatol Ther; 2022 Nov; 35(11):e15826. PubMed ID: 36101007
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: A retrospective study with a 6-year follow-up.
    Ahmed AR; Shetty S; Kaveri S; Spigelman ZS
    J Am Acad Dermatol; 2016 Apr; 74(4):700-8.e3. PubMed ID: 26851830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid.
    Amagai M; Ikeda S; Hashimoto T; Mizuashi M; Fujisawa A; Ihn H; Matsuzaki Y; Ohtsuka M; Fujiwara H; Furuta J; Tago O; Yamagami J; Tanikawa A; Uhara H; Morita A; Nakanishi G; Tani M; Aoyama Y; Makino E; Muto M; Manabe M; Konno T; Murata S; Izaki S; Watanabe H; Yamaguchi Y; Matsukura S; Seishima M; Habe K; Yoshida Y; Kaneko S; Shindo H; Nakajima K; Kanekura T; Takahashi K; Kitajima Y; Hashimoto K;
    J Dermatol Sci; 2017 Feb; 85(2):77-84. PubMed ID: 27876358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory antilaminin γ1 pemphigoid successfully treated with intravenous immunoglobulin and mycophenolate mofetil.
    Alloo A; Strazzula L; Rothschild B; Hawryluk E; Levine D; Hoang MP; Koga H; Hashimoto T; Kroshinsky D
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1401-3. PubMed ID: 24397852
    [No Abstract]   [Full Text] [Related]  

  • 15. Systemic Lupus Erythematosus and Bullous Pemphigoid with Dramatic Response to Dapsone.
    Maggio MC; Corsello G; Prinzi E; Cimaz R
    Am J Case Rep; 2017 Mar; 18():317-319. PubMed ID: 28352068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-p200 pemphigoid in a 17-year-old girl successfully treated with systemic corticosteroid and dapsone.
    Yamane N; Sawamura D; Nishie W; Abe M; Kodama K; Adachi K; Nakamura H; Ishii N; Hashimoto T; Shimizu H
    Br J Dermatol; 2007 May; 156(5):1075-8. PubMed ID: 17381449
    [No Abstract]   [Full Text] [Related]  

  • 17. Refractory childhood pemphigoid successfully treated with rituximab.
    Fuertes I; Luelmo J; Leal L; Romaní J; Sánchez S; Mascaró JM
    Pediatr Dermatol; 2013; 30(5):e96-7. PubMed ID: 23278674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bullous Pemphigoid Successfully Treated with Rituximab].
    Silva N; Costa A; Salvador F; Serradeiro E
    Acta Med Port; 2017 Mar; 30(3):243-246. PubMed ID: 28550834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bullous pemphigoid (BP) in an infant complicated by tuberculous meningoencephalitis.
    Nanda A; Nanda M; Dvorak R; Al-Sabah H; Alsaleh QA
    Int J Dermatol; 2007 Sep; 46(9):964-6. PubMed ID: 17822503
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous immunoglobulin treatment in laryngeal pemphigoid.
    Gürcan HM; Ahmed AR
    Clin Exp Dermatol; 2009 Dec; 34(8):884-6. PubMed ID: 19094130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.